Assoc. Prof. Dr. Ibrahim Ethem Pinar | Hematology | Best Researcher Award

Associate Professor | Bursa Uludag University | Turkey

Assoc. Prof. Dr. Ibrahim Ethem Pinar M.D., is an Associate Professor in the Department of Hematology at the Faculty of Medicine, Bursa Uludağ University, Türkiye. He completed his medical education and specialized training in internal medicine and hematology, establishing a strong academic and clinical foundation in the field. His research focuses on acute myeloid leukemia, FLT3-mutated AML, hematopoietic stem-cell transplantation, CMV reactivation, multiple myeloma prognostics, and the integration of artificial intelligence in hematology. Assoc. Prof. Dr. Ibrahim Ethem Pinar has authored impactful research articles published in reputed journals such as the International Journal of Hematology and Oncology, Therapeutic Apheresis and Dialysis, Clinical Lymphoma Myeloma and Leukemia, and Scientific Reports. His scholarly output includes 23 publications with 64 citations across 64 documents and an h-index of 5, reflecting his growing influence in the hematology research community. He has also contributed to book chapters discussing contemporary clinical approaches to hematologic diseases and nanotechnology applications in medicine. Recognized for his contributions to hematologic research, Assoc. Prof. Dr. Ibrahim Ethem Pinar has received multiple awards from the Turkish Society of Hematology and presented his studies at prestigious international conferences, including the American Society of Hematology and the European Society for Blood and Marrow Transplantation. A dedicated educator and clinician, he continues to advance the understanding and management of hematologic malignancies through innovative clinical and translational research. Assoc. Prof. Dr. Ibrahim Ethem Pinar is fluent in Turkish and English and remains deeply engaged in collaborative projects that bridge academic excellence with clinical practice in hematology.

Profile: Scopus | Orcid | Google Scholar

Featured Publications

Gursoy, V., Ozkalemkas, F., Ozkocaman, V., Yegen, Z. S., Pinar, I. E., Ener, B., … (2021). Conventional amphotericin B associated nephrotoxicity in patients with hematologic malignancies. Cureus, 13(7).

Acet-Öztürk, N. A., Ömer-Topçu, D., Vurat-Acar, K., Aydın-Güçlü, Ö., Pınar, İ. E., … (2022). Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy. Journal of Medical Mycology, 32(4), 101304.

Orhan, B., Özkalemkaş, F., Özkocaman, V., Gürbüz, B., Ersal, T., Pınar, İ. E., … (2022). The role of white blood cell count in perianal pathologies: A retrospective analysis of hematologic malignancies. Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022051.

Baysal, M., Gürsoy, V., Hunutlu, F. C., Erkan, B., Demirci, U., Bas, V., Gulsaran, S. K., … (2022). The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: A retrospective study. Annals of Hematology, 101(5), 1049–1057.

Ersal, T., Özkocaman, V., Pınar, İ. E., Yalçın, C., Orhan, B., Candar, Ö., Çubukçu, S., … (2023). Systemic inflammatory indices for predicting prognosis of myelofibrosis. Scientific Reports, 13(1), 12539.

Prof. Varda Shoshan-Barmatz | Cancer | Best Researcher Award

Ben-Gurion University, Life Sciences, Israel

Prof. Varda Shoshan-Barmatz is a renowned Professor of Molecular Physiology at Ben-Gurion University, Israel 🇮🇱. She completed her Ph.D. at the Weizmann Institute and pursued advanced training in the U.S. and Canada 🌎. She served as Director of the National Institute for Biotechnology in Israel (NIBN) from 2006 to 2015. With over 200 publications and 24 patents 🧬, she has been recognized by Forbes and Lady Globes among Israel’s most influential scientists. Her pioneering work focuses on novel therapeutic strategies for cancer and other diseases, influencing both academia and biotech industries 🌟.

Profile

Scopus

Education 🎓

Prof. Shoshan-Barmatz earned her Ph.D. at the prestigious Weizmann Institute of Science in Israel 📘. Further enhancing her expertise, she completed postdoctoral research in leading labs across the United States and Canada 🌎. Her academic journey laid a strong foundation for her breakthroughs in mitochondrial biology and disease therapy 🧪.

Experience 🧑‍🔬

Prof. Shoshan-Barmatz has extensive experience in academia and biotechnology 🏢. She was the founding director of the National Institute for Biotechnology in Israel and has mentored over 100 doctoral and postdoctoral fellows 👩‍🎓👨‍🎓. With involvement in five biotech companies and serving on multiple editorial boards, her leadership spans research, innovation, and entrepreneurship 🚀.

Research Interest 🔬

Her research centers on the mitochondrial protein VDAC1 and its role in diseases such as cancer, diabetes, Alzheimer’s, and metabolic liver diseases 🧬. Prof. Shoshan-Barmatz has innovated several therapeutic strategies by targeting VDAC1 to regulate apoptosis, energy metabolism, and immune responses, shaping the future of personalized medicine 🧠💊.

Awards 🏆

Prof. Shoshan-Barmatz’s groundbreaking contributions have earned her the prestigious Hestrin Prize, the Teva Founders Award, and the Ben-Gurion Award 🏅. She is celebrated as one of Israel’s most influential women in science by Forbes and Lady Globes 🌟, recognizing her impact on biotechnology and molecular research.

Publications 📚

“VDAC1-based peptides: Novel pro-apoptotic agents for cancer therapy” (2020, Cancers) Link here — Cited by 110 articles.

“The mitochondrial voltage-dependent anion channel 1, Ca2+ transport, apoptosis, and their regulation” (2012, Frontiers in Oncology) Link here — Cited by 420 articles.

“VDAC1, a multi-functional mitochondrial protein regulating cell life and death” (2017, Cell Stress) Link here — Cited by 310 articles.

“VDAC1 at the crossroads of cell metabolism, apoptosis and autophagy” (2015, Molecular and Cellular Oncology) Link here — Cited by 150 articles.

Conclusion

Prof. Varda Shoshan-Barmatz is highly suitable for the Best Researcher Award. Her exceptional achievements in research, innovation, mentorship, translational biotechnology, and global scientific leadership make her a distinguished candidate. Her work has had a profound and lasting impact on molecular biology, biotechnology, and medical sciences, fully aligning with the spirit of the award

Ibrahim Ethem Pinar | Hematology | Best Researcher Award

Assoc. Prof. Dr. Ibrahim Ethem Pinar | Hematology | Best Researcher Award